28 related articles for article (PubMed ID: 8765512)
1. Flexible cyclic ethers/polyethers as novel P2-ligands for HIV-1 protease inhibitors: design, synthesis, biological evaluation, and protein-ligand X-ray studies.
Ghosh AK; Gemma S; Baldridge A; Wang YF; Kovalevsky AY; Koh Y; Weber IT; Mitsuya H
J Med Chem; 2008 Oct; 51(19):6021-33. PubMed ID: 18783203
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of potent macrocyclic HIV-1 protease inhibitors involving P1-P2 ligands.
Ghosh AK; Schiltz GE; Rusere LN; Osswald HL; Walters DE; Amano M; Mitsuya H
Org Biomol Chem; 2014 Sep; 12(35):6842-54. PubMed ID: 25050776
[TBL] [Abstract][Full Text] [Related]
3. One ring to dissolve them all.
Halford JJ
Epilepsy Curr; 2015; 15(1):52-3. PubMed ID: 25678894
[No Abstract] [Full Text] [Related]
4. Direct Synthesis of Polyaromatic Cyclophanes Containing Bis-Methylene-Interrupted
D'yakonov VA; Islamov II; Dzhemileva LU; Makarova EK; Dzhemilev UM
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445489
[TBL] [Abstract][Full Text] [Related]
5. Aza-peptide analogs as potent human immunodeficiency virus type-1 protease inhibitors with oral bioavailability.
Fässler A; Bold G; Capraro HG; Cozens R; Mestan J; Poncioni B; Rösel J; Tintelnot-Blomley M; Lang M
J Med Chem; 1996 Aug; 39(16):3203-16. PubMed ID: 8759643
[TBL] [Abstract][Full Text] [Related]
6. Potent human immunodeficiency virus type 1 protease inhibitors that utilize noncoded D-amino acids as P2/P3 ligands.
Jungheim LN; Shepherd TA; Baxter AJ; Burgess J; Hatch SD; Lubbehusen P; Wiskerchen M; Muesing MA
J Med Chem; 1996 Jan; 39(1):96-108. PubMed ID: 8568831
[TBL] [Abstract][Full Text] [Related]
7. Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.
Beaulieu PL; Wernic D; Abraham A; Anderson PC; Bogri T; Bousquet Y; Croteau G; Guse I; Lamarre D; Liard F; Paris W; Thibeault D; Pav S; Tong L
J Med Chem; 1997 Jul; 40(14):2164-76. PubMed ID: 9216835
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
Ghosh AK; Swanson LM; Cho H; Leshchenko S; Hussain KA; Kay S; Walters DE; Koh Y; Mitsuya H
J Med Chem; 2005 May; 48(10):3576-85. PubMed ID: 15887965
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of HIV-1 proteinase containing 2-heterosubstituted 4-amino-3-hydroxy-5-phenylpentanoic acid: synthesis, enzyme inhibition, and antiviral activity.
Scholz D; Billich A; Charpiot B; Ettmayer P; Lehr P; Rosenwirth B; Schreiner E; Gstach H
J Med Chem; 1994 Sep; 37(19):3079-89. PubMed ID: 7932531
[TBL] [Abstract][Full Text] [Related]
10. Paracyclophanes: a novel class of water-soluble inhibitors of HIV proteinase.
Ettmayer P; Billich A; Hecht P; Rosenwirth B; Gstach H
J Med Chem; 1996 Aug; 39(17):3291-9. PubMed ID: 8765512
[TBL] [Abstract][Full Text] [Related]
11. Viral proteases as targets for chemotherapeutic intervention.
Hellen CU; Wimmer E
Curr Opin Biotechnol; 1992 Dec; 3(6):643-9. PubMed ID: 1369416
[TBL] [Abstract][Full Text] [Related]
12. HIV proteinase inhibitors.
Roberts NA; Craig JC; Duncan IB
Biochem Soc Trans; 1992 May; 20(2):513-6. PubMed ID: 1397651
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
